Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery

British Journal of Pharmacology

Volumn 138, Issue 7, 2003, Pages 1320-1332

  Ho, W S Vanessa ^a   Hiley, C Robin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Abnormal cannabidiol; Cannabinoid antagonists; Cannabinoid receptors; Cannabinoids; Ionomycin; Mesenteric artery (rat); Pertussis toxin; SR 141716A

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 4 [3 METHYL 6 (1 METHYLETHENYL) 2 CYCLOHEXEN 1 YL] 5 PENTYL 1,3 BENZENEDIOL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHLORIDE; CANNABIDIOL; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CHARYBDOTOXIN; IONOMYCIN; METHOXAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHLORIDE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME INHIBITION; GAP JUNCTION; INHIBITION KINETICS; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; BORNANES; CALCIUM CHANNELS; CALCIUM CHLORIDE; CANNABIDIOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; GAP JUNCTIONS; HETEROTRIMERIC GTP-BINDING PROTEINS; MALE; MESENTERIC ARTERIES; MYOGRAPHY; PIPERIDINES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; VASODILATION;

EID: 0038561226     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705160     Document Type: Article

References (55)

1. ADAMS, M.D., EARNHARDT, J.T., MARTIN, B.R., HARRIS, L.S., DEWEY, W.L. & RAZDAN, R.K. (1977). A cannabinoid with cardiovascular activity but no overt behavioural effects. Experientia, 33, 1204-1205.
2. AGURELL, S., HALLDIN, M., LINDGREN, J.E., OHLSSON, A., WIDMAN, M., GILLESPIE, H. & HOLLISTER, L. (1986). Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev., 38, 21-43.
3. BENOWITZ, N.L. & JONES, R.T. (1974). Cardiovascular effects of prolonged delta-9-tetrahydro-cannabinol ingestion. Clin. Pharmacol. Ther., 18, 287-297.
4. BISOGNO, T., HANUS, L., DE PETROCELLIS, L., TCHILIBON, S., PONDE, D.E., BRANDI, I., MORIELLO, A.S., DAVIS, J.B., MECHOULAM, R. & DI MARZO, V. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol., 134, 845-852.
5. BREIVOGEL, C.S., GRIFFIN, G., DI MARZO, V. & MARTIN, B.R. (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155-163.
6. 1 receptor-deficient mice. Hypertension, 39, 251-257.
7. BUSSE, R., EDWARDS, G., FELETOU, M., FLEMING, I., VANHOUTTE, P.M. & WESTON, A.H. (2002). EDHF: bringing the concepts together. Trends Pharmacol. Sci., 23, 374-380.
8. CHAYTOR, A.T., MARTIN, P.E., EVANS, W.H., RANDALL, M.D. & GRIFFITH, T.M. (1999). The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J. Physiol., 520, 539-550.
9. DE PETROCELLIS, L., BISOGNO, T., MACCARRONE, M., DAVIS, J.B., FINAZZI-AGRO, A. & DI MARZO, V. (2001). The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 276, 12856-12863.
10. DEUTSCH, D.G., GOLIGORSKY, M.S., SCHMID, P.C., KREBSBACH, R.J., SCHMID, H.H.O., DAS, S.K., DEY, S.K., ARREAZA, G., THORUP, C., STEFANO, G. & MOORE, L.C. (1997). Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest., 100, 1538-1546.
11. 2 receptor-mediated actions of anandamide in mouse brain. J. Neurochem., 75, 2434-2444.
12. ELLIS, E.F., MOORE, S.F. & WILLOUGHBY, K.A. (1995). Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am. J. Physiol., 269, H1859-H1864.
13. FACCI, R., DAL TOSO, R., ROMANELLO, S., BURUANI, A., SKAPER, S.D. & LEON, A. (1995). Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U.S.A., 92, 3376-3380.
14. FELDER, C.C., BRILEY, E.M., AXELROD, J., SIMPSON, J.T., MACKIE, K. & DEVANE, W.A. (1993). Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A., 90, 7656-7660.
15. FELDER, C.C. & GLASS, M. (1998). Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol., 38, 179-200.
16. 2 receptors. Mol. Pharmacol., 48, 443-450.
17. FORD, W.R., HONAN, S.A., WHITE, R. & HILEY, C.R. (2002). Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br. J. Pharmacol., 135, 1191-1198.
18. 1 receptors in vivo. J. Neurochem., 70, 417-423.
19. 2+ channel current. Am. J. Physiol., 276, H2085-H2093.
20. 1 receptor. J. Neurosci., 17, 5327-5333.
21. 2, a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. U.S.A., 25, 14228-14233.
22. HILLARD C.J. (2000). Endocannabinoids and vascular function. J. Pharmacol. Exp. Ther., 294, 27-32.
23. HOWLETT, A.C., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE, W.A., FELDER, C.C., HERKENHAM, M., MACKIE, K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors. Pharmacol. Rev., 54, 161-202.
24. 2 receptors. Proc. Natl. Acad. Sci. U.S.A., 96, 14136-14141.
25. KAGOTA, S., YAMAGUCHI, Y., MAKAMURA, K., SUGUIRA, T., WAKU, K. & KUNITOMO, M. (2001). 2-Arachidonylglycerol, a candidate of endothelium-derived hyperpolarizing factor. Eur. J. Pharmacol., 415, 233-238.
26. KARAKI, H., OZAKI, H., HORI, M., MITSUSAITO, M., AMINO, K.I., HARADA, K.I., MIYAMOTO, S., NAKAZAWA, H., WON, K.J. & SATO, K. (1997). Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev., 49, 157-230.
27. 1-like cannabinoid receptors. J. Pharmacol. Exp. Ther., 281, 1030-1037.
28. LAN, R., LIU, Q., FAN, P., LIN, S., FERNANDO, S.R., MCCALLION, D., PERTWEE, R. & MAKRIYANNIS, A. (1999). Structure - activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem., 42, 769-776.
29. LIU, C. & HERMANN, T.E. (1978). Characterization of ionomycin as a calcium ionophore. J. Biol. Chem., 253, 5892-5894.
30. LIU, H., XIONG, Z. & SPERELAKIS, N. (1997). Cyclic nucleotides regulate the activity of L-type calcium channels in smooth muscle cells from rat portal vein. J. Mol. Cell. Cardiol., 29, 1411-1421.
31. 1 receptor antagonist SR141716A on the behaviour of pigeons and rats. Psychopharmacology, 124, 315-332.
32. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
33. Ca) in smooth muscle cells isolated from the rat mesenteric artery. Br. J. Pharmacol., 124, 1131-1140.
34. 2+ in endothelial cells. Br. J. Pharmacol., 126, 1593-1600.
35. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterisation of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
36. 2+-induced relaxation of isolated mesenteric resistance arteries. Am. J. Physiol., 274, H1655-H1661.
37. MURPHY, M.E. & BRAYDEN, J.E. (1995). Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol., 486, 47-58.
38. OMAR, R., BOTTRILL, F.E., HILEY, C.R. & WHITE, R. (2000). Interaction of cyclic cAMP modulating agents with levcromakalim in the relaxation of rat isolated mesenteric artery. Eur. J. Pharmacol., 401, 85-96.
39. 1 cannabinoid receptor. Am. J. Physiol., 274, H375-H381.
40. RALEVIC, V., KENDALL, D.A., RANDALL, M.D., ZYGMUNT, P.M., MOHAVED, P. & HÖGESTÄTT, E.D. (2000). Vanilloid receptors on capsaicin-sensory nerves mediated relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries. Br. J. Pharmacol., 130, 1483-1488.
41. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284, 644-650.
42. 1 cannabinoid receptor isoforms. J. Pharmacol. Exp. Ther., 278, 871-878.
43. 2 cannabinoid receptors of L759633, L759656 and AM630. Br. J. Pharmacol., 126, 665-672.
44. SHIRE, D., CARILLOM, C., KAGHAD, M., CALANDRA, B., RINALDI-CARMONA, M., LE FUR, G., CAPUT, D. & FERRARA, P. (1995). An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem., 270, 3276-3731.
45. 2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 278, 989-999.
46. 1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol., 278, 279-283.
47. WAGNER, J.A., VARGA, K., JÁRAI, Z. & KUNOS, G. (1999). Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension, 33, 429-434.
48. WHITE, R. & HILEY, C.R. (1997). A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol., 122, 1573-1584.
49. WHITE, R. & HILEY, C.R. (1998a). Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicallamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery. Br. J. Pharmacol., 124, 1219-1226.
50. WHITE, R. & HILEY, C.R. (1998b). The actions of some cannabinoid receptor ligands in rat isolated mesenteric artery. Br. J. Pharmacol., 125, 533-541.
51. WHITE, R. & HILEY, C.R. (1998c). The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery. Br. J. Pharmacol., 125, 689-696.
52. + channel openers. Eur. J. Pharmacol., 397, 279-290.
53. WHITE, R., HO, W.-S.V., BOTTRILL, F.E., FORD, W.R. & HILEY, C.R. (2001). Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol., 134, 921-929.
54. ZYGMUNT, P.M., EDWARDS, G., WESTON, A.H., LARSSON, B., HÖGESTÄTT, E.D. (1997). Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery. Br. J. Pharmacol., 121, 141-149.
55. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SØRGÅRD, M., DI MARZO, V., JULIUS, D. & HÖGESTÄTT, E.D. (1999). Vanilloid receptors on sensory nerves mediate vasodilator action of anandamide. Nature, 400, 452-457.